Editors-in-Chief
Panteleimon Giannakopoulos, PhD, University of Geneva, Switzerland
Jason Huse, University of Texas MD Anderson Cancer Center, USA
Aims and scope
Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques
Investigating the Biology of Brain Metastases
This Collection aims to bring together the latest research on brain metastases biology.
Neuropathology and Neurodegeneration in the Retina
This Collection will highlight basic, translational, and clinical studies that address current knowledge gaps in retinal neurodegenerations.
Why publish with ANC?
- No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
- Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
- Rapid publication: publication within 2 months of submission
- Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
- Open access: enabling it to be read by a much larger set of readers, increasing its visibility
- Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees
Articles
-
-
Tppp3 is a novel molecule for retinal ganglion cell identification and optic nerve regeneration
-
A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in an AAV-C9ORF72 (G4C2)66 mouse model
-
3-Dimensional morphological characterization of neuroretinal microglia in Alzheimer’s disease via machine learning
-
JMJD3 deficiency disturbs dopamine biosynthesis in midbrain and aggravates chronic inflammatory pain
From the Editors-in-Chief
"The definition of the molecular and cellular background as well as pathogenetic pathways of neurological and psychiatric disorders is a major challenge of modern medicine. Neuropathology moves quickly from classical studies on histological characteristics of neurodegenerative, neurodevelopmental and mental disorders to the integration of complex models that include proteomics, transcriptomics and single cell analyses coupled with ad hoc behavioral investigations in animal models and humans. Acta Neuropathologica Communications provides a unique platform for rapidly published reports that involve clinical and experimental neuropathology. The broad scope of the journal covers clinical investigations in human samples, animal and in vitro studies on the molecular phenotypes but also reports on the complex interplay between environmental stressors, epigenetic regulation and cellular expression in neuropsychiatric diseases. Excellent papers that provide key contributions on the pathogenesis of brain pathologies are warmly welcome. We guarantee high quality reviews and fast publication that makes it possible to be at the cutting edge of scientific efforts in this challenging field. I look forward to receive your work!"
Panteleimon Giannakopoulos, co-Editor-in-Chief, ANC
"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand. ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead."
Jason T. Huse, co-Editor-in-Chief, ANC
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 6.2
5-year Journal Impact Factor: 6.8
Source Normalized Impact per Paper (SNIP): 1.344
SCImago Journal Rank (SJR): 2.580Speed 2023
Submission to first editorial decision (median days): 3
Submission to acceptance (median days): 50
Usage 2023
Downloads: 1,631,164
Altmetric mentions: 3,652